Page last updated: 2024-09-03

pramipexole and 3-n-methylspiperone

pramipexole has been researched along with 3-n-methylspiperone in 1 studies

Compound Research Comparison

Studies
(pramipexole)
Trials
(pramipexole)
Recent Studies (post-2010)
(pramipexole)
Studies
(3-n-methylspiperone)
Trials
(3-n-methylspiperone)
Recent Studies (post-2010) (3-n-methylspiperone)
1,10321951715567

Protein Interaction Comparison

ProteinTaxonomypramipexole (IC50)3-n-methylspiperone (IC50)
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.0013
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.0013
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.0013
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.0101
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Jiang, C; Keck, TM; Levant, B; Newman, AH; Wang, S1

Other Studies

1 other study(ies) available for pramipexole and 3-n-methylspiperone

ArticleYear
Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.
    Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11

    Topics: Animals; Arrestins; beta-Arrestins; Cell Line; Cyclobutanes; Humans; Male; Naphthalenes; Radioligand Assay; Rats, Sprague-Dawley; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship; Tranylcypromine

2014